Comprehensive Analysis of Biomarkers in Vulvar Cancer: Unveiling the Roles of EGFR, GLUT1, MUC1, MRP1, P16, PD-L1, and P53 – A Review

Abstract

Vulvar cancer remains a significant health concern for women worldwide. This comprehensive review provided an overview of biomarkers in vulvar cancer, focusing on the significance of EGFR, GLUT1, MUC1, MRP1, P16, PD-L1, and P53. It explores their prognostic value and pathophysiology, delving into the intricate landscape of these biomarkers. It was aimed to elucidate the roles of these biomarkers in predicting outcomes, offering insights into their potential as prognostic indicators for vulvar cancer. This analysis can contribute to the evolving understanding of molecular markers in the context of vulvar cancer prognosis and informs future research directions in the field.